Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
26 avr. 2024 06h16 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share...
Vedtægter for Novo Nordisk, april 2024
24 avr. 2024 08h57 HE
|
Novo Nordisk A/S
Vedtægter for Novo Nordisk, april 2024
Vedhæftet fil
Vedtægter 24 Apr 2024
...
Novo Nordisk A/S - Articles of Association, April 2024
24 avr. 2024 08h57 HE
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association, April 2024
Attachment
Articles of Association 24 Apr 2024
...
Novo Nordisk A/S – Reduction of the share capital
24 avr. 2024 08h48 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by...
Novo Nordisk A/S - share repurchase programme
22 avr. 2024 09h06 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
15 avr. 2024 13h39 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
15 avr. 2024 08h43 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
08 avr. 2024 09h40 HE
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 08 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Novo Nordisk A/S - share repurchase programme
02 avr. 2024 06h56 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
25 mars 2024 07h58 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 25 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...